|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 268.67 USD | +0.82% |
|
+4.64% | +6.35% |
| 11/12 | Baird Adjusts Price Target on Humana to $264 From $280, Maintains Neutral Rating | MT |
| 06/12 | Sector Update: Health Care Stocks Lower Late Afternoon | MT |
| Capitalization | 3.21TCr 2.73TCr 2.55TCr 2.4TCr 4.42TCr 2,90300Cr 4.83TCr 30TCr 12TCr 1,36800Cr 12TCr 12TCr 4,99300Cr | P/E ratio 2025 * |
21.2x | P/E ratio 2026 * | 22.3x |
|---|---|---|---|---|---|
| Enterprise value | 3.98TCr 3.39TCr 3.17TCr 2.98TCr 5.49TCr 3,60900Cr 6TCr 37TCr 14TCr 1,70100Cr 15TCr 15TCr 6,20600Cr | EV / Sales 2025 * |
0.31x | EV / Sales 2026 * | 0.28x |
| Free-Float |
60.46% | Yield 2025 * |
1.37% | Yield 2026 * | 1.49% |
Last Transcript: Humana Inc.
| 1 day | +0.82% | ||
| 1 week | +4.64% | ||
| Current month | +9.78% | ||
| 1 month | +12.20% | ||
| 3 months | -2.40% | ||
| 6 months | +14.84% | ||
| Current year | +6.35% |
| 1 week | 247.53 |  | 274.99 |
| 1 month | 221.5 | | 274.99 |
| Current year | 206.87 | | 315.35 |
| 1 year | 206.87 | | 315.35 |
| 3 years | 206.87 | | 541.21 |
| 5 years | 206.87 | | 571.3 |
| 10 years | 150 | | 571.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 54 | 01/07/2024 |
Celeste Brown
DFI | Director of Finance/CFO | 48 | 11/01/2025 |
Japan Mehta
CTO | Chief Tech/Sci/R&D Officer | 44 | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 64 | 01/01/2014 |
Frank D'Amelio
BRD | Director/Board Member | 67 | 01/09/2003 |
Karen Katz
BRD | Director/Board Member | 68 | 23/09/2019 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.3% | 5 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.82% | +4.64% | -1.09% | -49.09% | 3.21TCr | |
| +1.01% | +3.32% | -33.71% | -37.37% | 31TCr | |
| +0.04% | +9.15% | -4.60% | -32.42% | 8.01TCr | |
| +0.33% | +3.00% | -3.38% | -19.42% | 7.27TCr | |
| +1.26% | +6.94% | -29.31% | -52.81% | 1.99TCr | |
| +1.65% | +11.30% | -43.12% | -52.13% | 857.87Cr | |
| +1.31% | +0.87% | +77.34% | +64.47% | 388.38Cr | |
| +2.04% | +10.66% | +78.87% | -14.83% | 224.24Cr | |
| -0.55% | +6.40% | -8.50% | +147.30% | 142.09Cr | |
| -2.25% | -0.34% | -23.54% | - | 40Cr | |
| Average | +0.60% | +4.17% | +0.90% | -5.15% | 5.26TCr | |
| Weighted average by Cap. | +0.80% | +2.68% | -21.72% | -34.33% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 13TCr 11TCr 10TCr 9.67TCr 18TCr 11,69900Cr 19TCr 1,20000Cr 47TCr 5,51500Cr 48TCr 47TCr 20,12000Cr | 14TCr 12TCr 11TCr 11TCr 20TCr 12,99700Cr 22TCr 1,33300Cr 52TCr 6,12700Cr 54TCr 53TCr 22,35200Cr |
| Net income | 150.87Cr 128.53Cr 120.06Cr 112.96Cr 207.97Cr 14TCr 227.2Cr 1.4TCr 543.58Cr 6.44TCr 566.11Cr 554.17Cr 24TCr | 144.89Cr 123.43Cr 115.3Cr 108.48Cr 199.73Cr 13TCr 218.2Cr 1.35TCr 522.04Cr 6.19TCr 543.67Cr 532.21Cr 23TCr |
| Net Debt | 779.24Cr 663.83Cr 620.09Cr 583.43Cr 1.07TCr 71TCr 1.17TCr 7.24TCr 2.81TCr 33TCr 2.92TCr 2.86TCr 1,21400Cr | 766.34Cr 652.84Cr 609.83Cr 573.77Cr 1.06TCr 69TCr 1.15TCr 7.12TCr 2.76TCr 33TCr 2.88TCr 2.81TCr 1,19400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/25/13 | 269.68 $ | +1.20% | 5,78,289 |
| 11/25/11 | 266.49 $ | +3.83% | 19,02,247 |
| 10/25/10 | 256.66 $ | +2.50% | 10,46,980 |
| 09/25/09 | 250.39 $ | -2.34% | 9,70,674 |
| 08/25/08 | 256.39 $ | -0.57% | 12,82,147 |
Delayed Quote Nyse, December 13, 2025 at 12:26 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HUM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition